A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Industry Licensing Information Bookmark and Share

Partner with City of Hope

City of Hope’s primary interest is caring for and healing our patients.  To accomplish this goal, our researchers and clinicians are continuing to push the science of medicine forward. The Office of Technology Licensing assists in this process by facilitating partnerships with companies whose resources and commercial expertise help translate these basic discoveries into commercial products so they may one day be available to the public and improve the health and prosperity of our patients.

Below is a brief overview of some facts and statistics about City of Hope:
 
  • National Cancer Institute-designated comprehensive cancer center; ranked as a best cancer hospital by U.S.News & World Report
     
  • Translationally focused research institute with core areas of research in oncology, HIV/AIDS and diabetes
     
  • 38 active and 9 pending City of Hope investigational new drugs with the Food and Drug Administration
     
  • 300 ongoing clinical trials
     
  • 100 principal investigators
     
  • $323 million in research grants and royalties

Please contact the OTL team to inquire further about any available technologies or to simply learn more about City of Hope.
 

Featured Technology

 
Researchers have designed a mobile phone app that enables patients to improve their self management of diabetes via food and lifestyle choices. Learn more.
 
 
Previously Featured Technology
 
 
Licensing Opportunities
 
City of Hope has developed a range of new technologies many of which are available for licensing to established or startup companies.  Almost all of City of Hope's new technologies fall within the fields of Biotechnology, Pharmaceuticals, Diagnostics or Medical Devices.
 
Please browse the available technologies below:
 
 

Industry Licensing Information

Partner with City of Hope

City of Hope’s primary interest is caring for and healing our patients.  To accomplish this goal, our researchers and clinicians are continuing to push the science of medicine forward. The Office of Technology Licensing assists in this process by facilitating partnerships with companies whose resources and commercial expertise help translate these basic discoveries into commercial products so they may one day be available to the public and improve the health and prosperity of our patients.

Below is a brief overview of some facts and statistics about City of Hope:
 
  • National Cancer Institute-designated comprehensive cancer center; ranked as a best cancer hospital by U.S.News & World Report
     
  • Translationally focused research institute with core areas of research in oncology, HIV/AIDS and diabetes
     
  • 38 active and 9 pending City of Hope investigational new drugs with the Food and Drug Administration
     
  • 300 ongoing clinical trials
     
  • 100 principal investigators
     
  • $323 million in research grants and royalties

Please contact the OTL team to inquire further about any available technologies or to simply learn more about City of Hope.
 

Featured Technology

Featured Technology

 
Researchers have designed a mobile phone app that enables patients to improve their self management of diabetes via food and lifestyle choices. Learn more.
 
 
Previously Featured Technology
 
 
Licensing Opportunities
 
City of Hope has developed a range of new technologies many of which are available for licensing to established or startup companies.  Almost all of City of Hope's new technologies fall within the fields of Biotechnology, Pharmaceuticals, Diagnostics or Medical Devices.
 
Please browse the available technologies below:
 
 

Antibodies

Anti-Virals and Vaccines

Cell Base Therapies

Diagnostics

Disease Models

Gene Therapies

Medical Devices

Peptides and Aptamers

siRNA

Small Molecules

Overview
Office of Technology Licensing
City of Hope
1500 E. Duarte Rd.
Modular 101
Duarte, CA 91010
 
 
 
Center for Applied Technology Development (CATD)
The Sylvia R. and Isador A. Deutch Center for Applied Technology Development (CATD) offers broad expertise in technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs.

City of Hope Campus Map
 
 
 
 
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.


NEWS & UPDATES
  • Henry Ford said it well: “Working together is success.” For biomedical researchers, this is especially true. The challenges they face often require expertise from multiple fields to find answers and solutions. Scientists seeking cures for type 1 diabetes in particular must overcome biological, medical and techn...
  • Superheroes are making plenty of headlines as the summer blockbuster season opens. At City of Hope, a 9-year-old girl wept as she hugged her own superhero: someone who had the superpower of healing her cancer. He didn’t wear flashy armor or a cape, but rather a plaid shirt. He doesn’t have a secret ...
  • Known for his ability to bring together, and lead, effective research teams, world-renowned translational research scientist and physician Larry W. Kwak, M.D., Ph.D., has joined City of Hope in a key leadership role within the institution’s new Hematologic Malignancies and Stem Cell Transplantation Instit...
  • To detect melanoma, the most deadly form of skin cancer, at its earliest, most treatable stage, conduct a head-to-toe skin self-examination once a month to check for suspicious moles.   Unusual, or atypical, moles can ultimately develop into skin cancer. Here is the ABCDE guide to potentially cancerous mol...
  • “Superheroes,” “grateful” and “lifesavers”: All are words patients have used to describe their bone marrow donors. For donors, “a great feeling” and “the right thing to do” seems to sum up their view of donating the stem cells used to save someone’s life. Bone marrow transplants of...
  • Updated: May 1, 2015 More than a decade after joining the bone marrow registry during a blood drive at the United States Military Academy at West Point, Phil Ratcliff received a call that he was a match for a leukemia patient. By then, he’d left his military career to start his own financial business, married [...
  • Updated: May 1. For Lars Nijland, the reason to become a member of a bone marrow registry was simple. “I always thought there would be no easier way to save somebody’s life,” said the 24-year-old student at Germany’s University of Goettingen, who signed up for the registry during a drive on his campus. Ni...
  • Updated: May 1 No parent ever wants to see their child hurting or sick in any way. Joanne Cooper’s daughter Amanda wasn’t sick, though. She seemed healthy. Vibrant. A straight-A student whose only major health ailment had been bouts of stress-related nausea. Then a blood test revealed that Amanda – now 9 years ...
  • Noe Chavez became animated when he recalled the story: “We were running a health event, screening folks for diabetes,” said the enthusiastic City of Hope population health researcher, “and this man comes over and starts talking to us about the trouble he’s having with his eyes. I spoke with him, listened ...
  • When Keith McKinny, 29, was first diagnosed with lymphoma and leukemia in 2010, the first person he thought of was former boyfriend Jason Mullins. The two hadn’t been in contact with each other for some time, but McKinny couldn’t think of anyone else with whom he wanted to be during that difficult period....
  • Updated: May 1 Yesenia Portillo’s search for a bone marrow donor started close to home. Her brother, sister and seven cousins all underwent testing, but none of them were a close enough match to donate the bone marrow stem cells she desperately needed for her transplant. Yesenia, now almost 16, had always been ...
  • Some of City of Hope’s most high-impact achievements have arisen from City of Hope’s globally recognized bone marrow transplant (BMT) program. The annual Karl G. Blume – Gerhard Schmidt Memorial Lecture in Transplantation Biology & Medicine — commemorating two of the most influential and revered...
  • Guido Marcucci, M.D., wants to put himself out of business. A respected clinician and esteemed basic and translational scientist, Marcucci joins City of Hope as co-director of the Gehr Family Center for Leukemia Research within the Hematologic Malignancies and Stem Cell Transplantation Institute. In this positi...
  • To say that myelofibrosis patients need more treatment options would be an understatement. The severely low platelet counts, known as thrombocytopenia, that are one of the hallmark symptoms of the disease can lead to chronic fatigue and weakness that not only damage quality of life but, ultimately, shorten life...
  • Patients with metastatic colorectal cancer often stop responding to the primary drugs used against the disease, leaving them with few options and little hope. Determined to increase those options, doctors and researchers at City of Hope are conducting two clinical trials that could lead to new treatments for pe...